ROARABLE
FREE $100K
Today Screener Big Ideas Track Record 💰 $100K Arena 🎲 Predictions 🏛️ Insiders 8 Analysts
Stock Ratings / Health Care / DAVI / options
SNWV (51) XTNT (65) SRTS (41) CVRX (31) ⌘ Pro Terminal →

Davion Healthcare Plc (DAVI) Options Positioning, Max Pain & Unusual Sweeps

$1.49 -11.31% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $1.46

Davion Healthcare Plc (DAVI) carries a Roarable Rating of D (Sell) with 47/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D • SELL / AVOID Cap $42.0M
📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on DAVI Below — or Connect Your Own ChatGPT / Claude
🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is DAVI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
▼

As of 2026-11-03, Davion Healthcare Plc (NASDAQ: DAVI) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $1.49 (-11.31% 1D, market cap $42.0M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 9/20. Across 1015 tracked Health Care issuers, DAVI ranks #313 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief
🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does DAVI compare to SNWV and XTNT in the Health Care sector?
▼

Within the Health Care sector (Medical/Dental Instruments), DAVI carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, SNWV (SANUWAVE Health Inc.) holds a D grade (51/100 RQD, P/E 3.8x, ROIC 67.3%, cap $44.3M) and XTNT (Xtant Medical Holdings Inc.) posts a C grade (65/100 RQD, P/E N/A, ROIC 12.8%, cap $39.3M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).

✓ Pre-computed one-to-many AI Quant brief
🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for DAVI?
▼

For Davion Healthcare Plc (DAVI), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity and sector rank #313 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief
🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
🛡️ Portfolio Crash X-Ray
EXT / AFTER-HRS: $1.46 (-2.23%)🧬 Disciplined Float (-0.40% YoY Shares)⚙️ Cash Engine: 12/20 (C-) • 0% FCF Margin
Verify 90D Bucket Audit →
📊 Historical Track Record Warning: Scores below 50 (47/100 · D) historically underperformed SPY in 71% of rolling 90-day windows (-5.9% avg 90D alpha vs SPY • 29.0% hit rate).
Audit Bucket Track Record →
RQD QUANT TACHOMETERSELL / AVOID • D
025507510047
JEV AI Jury Split (Battleground)
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw D- · Rk D+
Cash (12)Whales (3)SEC (13)Macro (10)CEO (9)
Each axis scored 0–20
12M PRICE TARGET CONE-4.7% Base Target
$3 Bull$1 Base$1 Bear
📬 FREE DAVI RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for DAVI)Realized 20D OHLCV Swing Band: ±4.2%
Deterministic 5-Pillar Attribution (47/100 Composite)
🔍 WHY DAVI SCORES 47/100 (D) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
▲ #1 Bullish Driver: SEC 10-K Forensic Risk+13/20 pts (28% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) • Piotroski F-Score 7/9

▲ #2 Bullish Driver: Cash Engine Quality+12/20 pts (26% of score)

SEC XBRL Trailing 12 Months: 0% FCF Margin ($1.2M FCF) & 52% Gross Margin

▼ #1 Drag / Risk Factor: Whale & Options Positioning4/20 pts (-16 pt drag)

Put hedging (50% put share) caps near-term gamma upside (-16 pts vs max)

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current
Q1 (-3Q)
39
Grade E$1.36+2.9% Next Q
Q2 (-2Q)
42
Grade D$1.40+1.4% Next Q
Q3 (-1Q)
44
Grade D$1.42+4.9% Next Q
Current
47
Grade D$1.49-5.9% Hist 90D α
Trajectory: E (39) → D (47)Full Audit →
⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

⚔️ Adversarial Opposing Case: What Could Spark a DAVI Turnaround Squeeze

Gideon Ashmere Forensic Desk →

While DAVI currently carries a cautious 47/100 (D) rating due to Whale & Options Positioning (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

🚀 Contrarian Squeeze Trigger #1

Established market leader in Health Care with deep daily trading liquidity.

🚀 Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($2.97) and Max Pain ($1.56) forces dealer call-delta covering toward $3.37.

🚀 Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Disciplined Float (-0.40% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $DAVI• $2.4M Crowd Pool • Kalshi / Polymarket Composite
Contract: “DAVI Beats Next Quarter EPS Consensus (Upcoming Quarter) & Holds Above 200D SMA”
YES 47%NO 53%Trade / Inspect Odds →
CALL VS. PUT WHALE SHARE
— (No Active Options Snapshot)
Put/Call Ratio: — (No Active Options Snapshot)
MAX-PAIN EXPIRATION MAGNET
— (No Active Options Snapshot)
No active options chain max-pain snapshot on file
HISTORICAL 20D VOLATILITY SWING
±4.2%
Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (DAVI)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for DAVI.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →
ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring DAVI)

  • ✓Walkthrough of DAVI's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • ✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • ✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
Join Founding VIP Waitlist (No Card Required) →$100K Arena
DAVI // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +0.68%📐 HORIZONTAL RANGE
2026-11-03O $1.51H $1.53L $1.51C $1.49VOL 18.50M
RES: $1.57SUP: $1.46SMA50: $2.97SMA200: $2.91
$3.08$2.63$2.18$1.74$1.29RES $1.57SUP $1.46$1.492026-09-042026-09-192026-10-042026-10-192026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

DAVI Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 DAVI Butterfly Map → + Track DAVI →
Share Count & Dilution Monitor

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle
8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger

No active Ellis Vennor swing setup published on DAVI today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for DAVI. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for DAVI today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (DAVI)

Health Care Rank #313 of 1015 ⚔️ SNWV vs DAVI Full Matrix →

1. Head-to-Head Health Care Peer Comparison (DAVI vs. SNWV, XTNT, SRTS, CVRX)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1015 tracked Health Care securities in the Roarable RQD universe, Davion Healthcare Plc (DAVI) ranks #313 by composite RQD confidence (47/100, grade D) and #766 by equity capitalization ($42.0M). Within this direct 5-issuer industry benchmark cohort, SNWV leads on earnings valuation at 3.8x trailing P/E, while SNWV leads on capital efficiency and profitability with 67.3% ROIC and 77.1% gross margin. XTNT currently holds the highest overall quantitative score in the immediate peer group at 65/100 (C) compared with DAVI at 47/100 (D).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
DAVI ACTIVE
Davion Healthcare Plc
D 47/100 — — — -11.31% $42.0M Benchmark Subject
SNWV
SANUWAVE Health Inc.
D 51/100 3.8x 77.1% 67.3% +13.59% $44.3M /snwv-vs-davi →
XTNT
Xtant Medical Holdings Inc.
C 65/100 — 62.9% 12.8% -0.64% $39.3M /xtnt-vs-davi →
SRTS
Sensus Healthcare Inc.
D- 41/100 — 43.2% -31.3% -0.36% $45.4M /srts-vs-davi →
CVRX
CVRx Inc.
E 31/100 — 85.3% -35.0% -2.84% $37.6M /cvrx-vs-davi →

2. DAVI Fundamental Profitability, Capital Efficiency & Balance-Sheet Forensics

TRAILING 12M & FORWARD QUANTITATIVE SNAPSHOT

Davion Healthcare Plc (DAVI) operates in Medical/Dental Instruments (Health Care) with an equity capitalization of $42.0M, trailing P/E of N/A, forward P/E of N/A, and EV/EBITDA of N/A. Operating profitability registers a gross margin of —, operating margin of —, net profit margin of —, ROIC of —, and free cash flow yield of —, alongside an Altman Z-Score of N/A and Piotroski F-Score of N/A.

3. DAVI Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is DAVI stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Davion Healthcare Plc (NASDAQ: DAVI) is rated D (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 47/100 at a spot price of $1.49 (-11.31% 1D, market cap $42.0M). Pillar breakdown: Fundamental Cash Engine 12/20, Institutional 13F & Options Flow 3/20, SEC Balance-Sheet Forensics 13/20, FRED Macro Regime Fit 10/20, and Executive Insider Alignment 9/20. Across 1015 tracked Health Care issuers, DAVI ranks #313 in composite RQD confidence.

How does DAVI compare to SNWV and XTNT in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), DAVI carries a Roarable D (47/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of —. By comparison, SNWV (SANUWAVE Health Inc.) holds a D grade (51/100 RQD, P/E 3.8x, ROIC 67.3%, cap $44.3M) and XTNT (Xtant Medical Holdings Inc.) posts a C grade (65/100 RQD, P/E N/A, ROIC 12.8%, cap $39.3M). Among the 5-stock peer group, SNWV leads on earnings multiple (3.8x) while SNWV leads on capital efficiency (67.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for DAVI?

For Davion Healthcare Plc (DAVI), key quantitative strengths include Established market leader in Health Care with deep daily trading liquidity and sector rank #313 in Health Care, while primary risk factors center on Company executives have done more routine share selling than personal cash buying lately and Sensitive to high interest rates and tighter Federal Reserve market liquidity.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is DAVI trading relative to its 50-day, 200-day, and 52-week technical levels?

DAVI last traded at $1.49 (-11.31% on volume of 429,553 shares), positioning the stock -49.83% below its 50-day simple moving average ($2.97) and -48.80% below its 200-day simple moving average ($2.91). Across its 52-week range of $1.68 to $3.21, DAVI sits at the 0.0% percentile with a 14-day RSI of 18.0 (OVERSOLD (<32)) and an implied next-earnings move of ±4.2% ($1.43 to $1.55).

Direct Sub-Reports: DAVI RQD Cockpit DAVI 12M Forecast DAVI Earnings & Move DAVI Dividends & DRIP DAVI Insiders & 13F DAVI Whale Options DAVI Profit Sankey DAVI News & Why
ROARABLE RATING BRIEF • RQD 47/100 (D) ✓ SEC XBRL & RQD VERIFIED

DAVI — Davion Healthcare Plc: What the Facts Mean to a Prospective Investor

Methodology: RQD v6.2 Deterministic 5-Pillar & SEC XBRL Audit
Updated: 2026-11-03

1. Roarable Rating Brief: What This Means to a Prospective Investor

Davion Healthcare Plc (DAVI) earns a live Roarable RQD composite score of 47/100, corresponding to a D letter grade (Roarable Sell) at a spot price of $1.49 (-11.31% 1D, market capitalization $42.0M).

  • Fundamental Cash Engine (12/20): Anchored by return on invested capital (ROIC) of —, gross margin of —, operating margin of —, and free cash flow yield of —.
  • Whale 13F & Options Flow (3/20) + Insider Conviction (9/20): Tracks institutional 13F accumulation, CBOE options call/put positioning, and SEC Form 4 / Congressional PTR filings.
  • Macro Regime Fit (10/20) + Forensic Balance Sheet (13/20): Incorporates a 1.00x equity beta, Altman Z-Score of N/A, Piotroski F-Score of N/A, and Debt/Equity of N/A.

2. Business Model, Unit Margins & SEC Financial Trajectory

Davion Healthcare Plc (DAVI) is a NASDAQ-listed issuer in the Health Care sector, Medical/Dental Instruments industry,. The profile does not describe its products, customers, or revenue model. — for the specifics of what the company sells, to whom, or how it earns revenue.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • 🐂 Primary Bull Case (D • RQD 47/100): Established market leader in Health Care with deep daily trading liquidity. Free cash flow yield of — and institutional whale pillar of 3/20. With Fundamental Cash Engine at 12/20 and Institutional Whale Flow at 3/20, sustained execution supports upside toward the upper end of the $1.68 – $3.21 52-week range.
  • 🐻 Primary Bear Case & Valuation Risk: Company executives have done more routine share selling than personal cash buying lately. Investors must weigh current valuation against — operating margins and a 1.00x macro beta.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

The source data therefore identifies no upstream suppliers, downstream customers, or sector correlation pathways. — for dependency mapping or 2nd-order bottleneck analysis. The sector and industry classification (Health Care; Medical/Dental Instruments) is the only available context.

  • Key Question #1: Can DAVI sustain or expand its — operating margin and — ROIC against Medical/Dental Instruments peers over the next 4 quarters?
  • Key Question #2: Will free cash flow conversion (— FCF yield) strengthen balance-sheet liquidity (Altman Z-Score N/A) toward the $3.21 52-week high?
  • Key Question #3: How sensitive is DAVI's equity valuation to Health Care capital spending cycles and macro interest-rate shifts (Beta 1.00x)?

DAVI Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Davion Healthcare Plc (DAVI) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to DAVI Debate Forum (3) ↓
🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

DAVI Bull vs. Bear Conversation Board — What's Your Call at $1.49?

🐂 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON DAVI 🐻 33% BEARISH CONVICTION
1. Pick Your Side on DAVI:
💡 Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
DE DeepValue_CFA RQD DEBATE OPENER • Institutional Buy-Side 🐂 BULLISH 🎯 Target: $2.00 (+19.0%)
📌 Pinned Debate

The balance sheet scores 13 of 20 on Altman Z 2.5, Piotroski F 6/9, and Debt/Equity 0.5, the strongest pillar on the rating.

Don't sleep on DAVI's setup in Health Care. The balance sheet scores 13 of 20 on Altman Z 2.5, Piotroski F 6/9, and Debt/Equity 0.5, the strongest pillar on the rating.. Beta of 1.0 means it moves fast when momentum turns, and the 5-pillar RQD gauge (47/100) backs up the fundamental quality.

SectorRotator 🐂 BULL

@DeepValue_CFA Agree on the RQD 47/100 quality, though with 1.0 beta I'm scaling in with half-size at $1.68 and keeping dry powder in case we test $1.56.

BE BearTrap_Alert RQD DEBATE OPENER • Cycle Peak Watcher 🐻 BEARISH 🎯 Target: $1.33 (-20.8%)
Spot @ $1.68

The whale/13F flow pillar scores only 3 of 20 while ROIC and FCF yield are both reported at 0%.

Here is the bear case nobody on the bull side wants to address on DAVI: The whale/13F flow pillar scores only 3 of 20 while ROIC and FCF yield are both reported at 0%.. At current EV/EBITDA multiples, even a small guidance miss in Medical/Dental Instruments triggers a 12-15% air pocket.

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%